Affiliation:
1. Department of Cardiology Zhongda Hospital Medical School of Southeast University Nanjing China
2. Department of Biochemistry and Molecular Biology Medical University of South Carolina Charleston SC
Abstract
Background
Kallistatin exerts beneficial effects on organ injury by inhibiting oxidative stress and inflammation. However, the role of kallistatin in atherosclerosis is largely unknown. Here, we investigated the role and mechanisms of kallistatin in patients with coronary artery disease (
CAD
), atherosclerotic plaques of apoE
−/−
mice, and endothelial activation.
Methods and Results
Plasma kallistatin levels were analyzed in 453 patients at different stages of
CAD
. Kallistatin levels were significantly lower in patients with
CAD
and negatively associated with
CAD
severity and oxidative stress. Human kallistatin
cDNA
in an adenoviral vector was injected intravenously into apoE
−/−
mice after partial carotid ligation, with or without nitric oxide synthase inhibitor (N
ω
‐nitro‐L‐arginine methyl ester) or sirtuin 1 inhibitor (nicotinamide). Kallistatin gene delivery significantly reduced macrophage deposition, oxidative stress, and plaque volume in the carotid artery, compared with control adenoviral injection. Kallistatin administration increased endothelial nitrous oxide synthase, sirtuin 1, interleukin‐10, superoxide dismutase 2, and catalase expression in carotid plaques. The beneficial effects of kallistatin in mice were mitigated by N
ω
‐nitro‐L‐arginine methyl ester or nicotinamide. Furthermore, human kallistatin protein suppressed tumor necrosis factor‐α–induced
NADPH
oxidase activity and increased endothelial nitrous oxide synthase and sirtuin 1 expression in cultured human endothelial cells. These effects were also abolished by N
ω
‐nitro‐L‐arginine methyl ester or nicotinamide.
Conclusions
This was the first study to demonstrate that reduced plasma kallistatin levels in patients are associated with
CAD
severity and oxidative stress. Kallistatin treatment prevents carotid atherosclerotic plaque formation in mice by stimulating the sirtuin 1/endothelial nitrous oxide synthase pathway. These findings indicate the potential protective effects of kallistatin on atherosclerosis in human subjects and mouse models.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献